Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc T.VMD


Primary Symbol: VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by LongTerm3on Jun 03, 2022 10:17am
266 Views
Post# 34729425

Yesterday's Call:

Yesterday's Call:The call was informative:

Said 2nd quarter over last year 2nd quarter growth will be 23 percent, and growing. Second quarter getting back to normal.

Making progress with VA. They are doing pilot study with 50 to 100 patients.

Pursue strategic acquisitions. Multiples coming down.

Philips recall - everyone got hit, but we bought enough equipment at beginning, and have equipment.

No supply chain issues.

A respiratory therapist can handle 50 to 60 patients each.

Inflation raise next year likely.

Probably no competitive bidding. 

Need good sales people, Not Covid issues.

<< Previous
Bullboard Posts
Next >>